Notice of Proposals to Engage in Permissible Nonbanking Activities or to Acquire Companies that are Engaged in Permissible Nonbanking Activities, 15756-15757 [E8-5970]
Download as PDF
<![CDATA[
15756
Federal Register / Vol. 73, No. 58 / Tuesday, March 25, 2008 / Notices
Kvamme, a Partner at Kleiner Perkins
Caufield & Byers.
M. David Hodge,
Operations Manager, Office of Science and
Technology Policy.
[FR Doc. E8–5950 Filed 3–24–08; 8:45 am]
BILLING CODE 3170–W8–P
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than April 9,
2008.
A. Federal Reserve Bank of
Minneapolis (Jacqueline G. King,
Community Affairs Officer) 90
Hennepin Avenue, Minneapolis,
Minnesota 55480-0291:
1. Louis B. Olsen, Eagan, Minnesota;
to acquire voting shares of Northern Star
Financial, Inc., Mankato, Minnesota,
and thereby indirectly gain control of
Northern Star Bank, Mankato,
Minnesota.
Board of Governors of the Federal Reserve
System, March 20, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8–5972 Filed 3–24–08; 8:45 am]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
mstockstill on PROD1PC66 with NOTICES
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
VerDate Aug<31>2005
18:33 Mar 24, 2008
Jkt 214001
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than April 18, 2008.
A. Federal Reserve Bank of
Richmond (A. Linwood Gill, III, Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261-4528:
1. Alliance Financial Corporation,
Gastonia, North Carolina; to become a
bank holding company by acquiring 100
percent of Alliance Bank and Trust
Company, Gastonia, North Carolina.
B. Federal Reserve Bank of Atlanta
(David Tatum, Vice President) 1000
Peachtree Street, N.E., Atlanta, Georgia
30309:
1. Resurgens Bancorp, Inc., Atlanta,
Georgia; to become a bank holding
company by acquiring 100 percent of
the outstanding voting shares of
Resurgens bank, Atlanta, Georgia (in
organization).
C. Federal Reserve Bank of Dallas
(W. Arthur Tribble, Vice President) 2200
North Pearl Street, Dallas, Texas 752012272:
1. Central Bancorp, Inc., Garland,
Texas; to acquire 100 percent of the
voting shares of Jones County Bank,
Haddock, Georgia.
Board of Governors of the Federal Reserve
System, March 20, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8–5971 Filed 3–24–08; 8:45 am]
BILLING CODE 6210–01–S
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
FEDERAL RESERVE SYSTEM
Sunshine Act Meeting
Board of
Governors of the Federal Reserve
System.
TIME AND DATE: 11:30 a.m., Monday,
March 31, 2008.
PLACE: Marriner S. Eccles Federal
Reserve Board Building, 20th and C
Streets, N.W., Washington, D.C. 20551.
STATUS: Closed.
MATTERS TO BE CONSIDERED:
1. Personnel actions (appointments,
promotions, assignments,
reassignments, and salary actions)
involving individual Federal Reserve
System employees.
2. Any items carried forward from a
previously announced meeting.
FOR FURTHER INFORMATION CONTACT:
Michelle Smith, Director, or Dave
Skidmore, Assistant to the Board, Office
of Board Members at 202–452–2955.
SUPPLEMENTARY INFORMATION: You may
call 202–452–3206 beginning at
approximately 5 p.m. two business days
before the meeting for a recorded
announcement of bank and bank
holding company applications
scheduled for the meeting; or you may
contact the Board’s Web site at https://
www.federalreserve.gov for an electronic
announcement that not only lists
applications, but also indicates
procedural and other information about
the meeting.
AGENCY HOLDING THE MEETING:
Board of Governors of the Federal Reserve
System, March 21, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 08–1074 Filed 3–21–08; 1:53 pm]
BILLING CODE 6210–01–S
FEDERAL RESERVE SYSTEM
Notice of Proposals to Engage in
Permissible Nonbanking Activities or
to Acquire Companies that are
Engaged in Permissible Nonbanking
Activities
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y (12
CFR Part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
E:\FR\FM\25MRN1.SGM
25MRN1
Federal Register / Vol. 73, No. 58 / Tuesday, March 25, 2008 / Notices
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act. Additional information on all
bank holding companies may be
obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than April 9, 2008.
A. Federal Reserve Bank of Chicago
(Burl Thornton, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690-1414:
1. First Fontanelle Employee Stock
Ownership Plan and Trust, Fontanelle,
Iowa; to indirectly engage in insurance
agency activities through Corn Belt
Insurance Agency, Massena, Iowa, and
thereby indirectly acquire First
Fontanelle Bancorporation, Fontanelle,
Iowa pursuant to section
225.28(b)(11)(iii)(A) of Regulation Y.
Board of Governors of the Federal Reserve
System, March 20, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc.E8–5970 Filed 3–24–08; 8:45 am]
BILLING CODE 6210–01–S
mstockstill on PROD1PC66 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP);
NTP Interagency Center for the
Evaluation of Alternative Toxicological
Methods (NICEATM); Availability of the
Interagency Coordinating Committee
on the Validation of Alternative
Methods (ICCVAM) Test Method
Evaluation Report: In Vitro Cytotoxicity
Test Methods for Estimating Starting
Doses for Acute Oral Systemic Toxicity
Tests and the Final Background
Review Document for In Vitro
Cytotoxicity Test Methods for
Estimating Acute Oral Systemic
Toxicity; Notice of Transmittal of
ICCVAM Test Method
Recommendations to Federal
Agencies
National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health
(NIH).
AGENCY:
VerDate Aug<31>2005
18:33 Mar 24, 2008
Jkt 214001
Availability of ICCVAM Test
Method Evaluation Report and Final
Background Review Document.
ACTION:
SUMMARY: NICEATM announces
availability of the ICCVAM Test Method
Evaluation Report: In Vitro Cytotoxicity
Test Methods for Estimating Starting
Doses for Acute Oral Systemic Toxicity
Tests (NIH Publication 07–4519). The
report describes two in vitro basal
cytotoxicity neutral red uptake (NRU)
test methods that can be used for
estimating starting doses for acute oral
toxicity tests. The report includes
ICCVAM’s (a) final test method
recommendations on the use of these
two test methods, (b) recommended test
method protocols for future use, (c)
recommendations for future studies to
further characterize the usefulness and
limitations of in vitro methods for
assessing acute systemic toxicity, and
(d) recommended performance
standards for tests with similar
scientific principles and that measure or
predict acute oral systemic toxicity. The
report recommends the use of these
methods in a weight-of-evidence
approach to determine starting doses for
acute oral systemic toxicity tests with
rodents. The report also recommends
that these in vitro test methods be
considered before using animals for
acute oral systemic toxicity testing and
used when determined appropriate.
NICEATM also announces the
availability of the final Background
Review Document: In Vitro Cytotoxicity
Test Methods for Estimating Acute Oral
Systemic Toxicity (BRD) (NIH
Publication 07–4518). The BRD
provides data and analyses from a
collaborative international validation
study organized by NICEATM and the
European Centre for the Validation of
Alternative Methods (ECVAM) to
evaluate the usefulness and limitations
of two in vitro basal cytotoxicity NRU
test methods using either BALB/c 3T3
mouse fibroblasts (3T3) or primary
human epidermal keratinocytes (NHK)
for estimating acute oral rodent toxicity.
Electronic copies of the ICCVAM Test
Method Evaluation Report and the BRD
are available from the ICCVAM/
NICEATM Web site at https://
iccvam.niehs.nih.gov or by contacting
NICEATM (see FOR FURTHER
INFORMATION CONTACT). The ICCVAM
Test Method Evaluation Report and the
final BRD have been forwarded to U.S.
Federal agencies for regulatory and
other acceptance considerations where
applicable. Responses will be posted on
the ICCVAM/NICEATM Web site as
they are received.
FOR FURTHER INFORMATION CONTACT: Dr.
William S. Stokes, Director, NICEATM,
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
15757
NIEHS, P.O. Box 12233, MD EC–17,
Research Triangle Park, NC 27709,
(phone) 919–541–2384, (fax) 919–541–
0947, (e-mail) niceatm@niehs.nih.gov.
Courier address: NICEATM, NIEHS, 79
T.W. Alexander Drive, Building 4401,
Room 3128, Research Triangle Park, NC
27709.
SUPPLEMENTARY INFORMATION:
Background
In 2002, NICEATM and ECVAM
initiated a collaborative, international,
multi-laboratory validation study to
independently evaluate the usefulness
of the 3T3 and NHK NRU basal
cytotoxicity test methods for estimating
acute oral rodent toxicity and for
estimating starting doses for in vivo
rodent acute oral toxicity tests. The 3T3
and NHK NRU test methods were
evaluated with 72 reference substances.
Once the study was completed in
January 2005, NICEATM prepared a
draft BRD that contained comprehensive
summaries of the data generated in the
validation study, analyses of the
relevance and reliability of the two test
methods, and simulation analyses of the
refinement (i.e., to lessen or avoid pain
and distress) and reduction in animal
use that might occur if these tests were
used as adjuncts to two acute oral
toxicity test methods (i.e., the Up-andDown Procedure and the Acute Toxic
Class method). The draft BRD was
released for public comment on March
21, 2006 (Federal Register, Vol. 71, No.
54, pp. 14229–14231).
On May 23, 2006, NICEATM, on
behalf of ICCVAM, convened an
independent, scientific peer review
panel meeting to review the draft BRD
and evaluate the validation status of the
3T3 and NHK NRU test methods for
determining starting doses for in vivo
acute oral systemic toxicity tests. The
peer review panel’s report was released
in July 2006 (Federal Register, Vol. 71,
No. 132, pp. 39122–39123). At a public
teleconference meeting on August 3,
2006 (Federal Register, Vol. 71, No. 132,
pp. 39121–39122), the Scientific
Advisory Committee on Alternative
Toxicological Methods (SACATM)
reviewed and endorsed the conclusions
of the peer review panel (minutes from
the teleconference are available at
https://ntp.niehs.nih.gov/files/
SACATMAug06MinutesVF081506.pdf).
ICCVAM considered the peer panel
report, public comments, SACATM
comments, and the draft BRD in
finalizing its recommendations on the
use of these two in vitro basal
cytotoxicity test methods for estimating
starting doses for acute oral systemic
toxicity tests. The ICCVAM Test Method
Evaluation Report includes the ICCVAM
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 73, Number 58 (Tuesday, March 25, 2008)]
[Notices]
[Pages 15756-15757]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5970]
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Notice of Proposals to Engage in Permissible Nonbanking
Activities or to Acquire Companies that are Engaged in Permissible
Nonbanking Activities
The companies listed in this notice have given notice under section
4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and
Regulation Y (12 CFR Part 225) to engage de novo, or to acquire or
control voting securities or assets of a company, including the
companies listed below, that engages either directly or through a
subsidiary or other company, in a nonbanking activity that is listed in
Sec. [thinsp]225.28 of Regulation Y (12 CFR 225.28) or that the Board
has determined by Order to be closely related to banking and
permissible for
[[Page 15757]]
bank holding companies. Unless otherwise noted, these activities will
be conducted throughout the United States.
Each notice is available for inspection at the Federal Reserve Bank
indicated. The notice also will be available for inspection at the
offices of the Board of Governors. Interested persons may express their
views in writing on the question whether the proposal complies with the
standards of section 4 of the BHC Act. Additional information on all
bank holding companies may be obtained from the National Information
Center website at www.ffiec.gov/nic/.
Unless otherwise noted, comments regarding the applications must be
received at the Reserve Bank indicated or the offices of the Board of
Governors not later than April 9, 2008.
A. Federal Reserve Bank of Chicago (Burl Thornton, Assistant Vice
President) 230 South LaSalle Street, Chicago, Illinois 60690-1414:
1. First Fontanelle Employee Stock Ownership Plan and Trust,
Fontanelle, Iowa; to indirectly engage in insurance agency activities
through Corn Belt Insurance Agency, Massena, Iowa, and thereby
indirectly acquire First Fontanelle Bancorporation, Fontanelle, Iowa
pursuant to section 225.28(b)(11)(iii)(A) of Regulation Y.
Board of Governors of the Federal Reserve System, March 20,
2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc.E8-5970 Filed 3-24-08; 8:45 am]
BILLING CODE 6210-01-S
